Mark Mahaney, Evercore ISI head of internet research, joins 'Closing Bell' to discuss the markets, Meta's historic winning ...

Investing.com -- Evercore ISI added Wendy’s Co to its Tactical Outperform list ahead of the company’s investor day on March 6 ...

Shares of Vera Therapeutics (VERA) sold off about 20% on Friday following news in competitor Otsuka’s 2024 earnings presentation that the ...

Evercore ISI notes that the fourth-generation iPhone SE is expected to be released sometime around March, with a launch announcement expected ...

Specialty MGA Optio Group has retained investment bank Evercore with a mandate to explore its debt options, as the business ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) ...

Private equity firm Sycamore Partners' bid to acquire Walgreens Boots Alliance and take it private is reportedly still possible.

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) was upgraded by Evercore ISI from an “in-line” rating to an “outperform” ...

Walgreens Boots Alliance Inc. is getting advice from Perella Weinberg Partners and AlixPartners for help with its operations ...

Teradata (NYSE:TDC – Free Report) had its target price cut by Evercore ISI from $37.00 to $32.00 in a research report report ...

Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...